PURPOSE To present MR findings of parenchymal brain injury after accelerated
fractionation radiation therapy combined with carboplatin chemotherapy in the treatment of …

PURPOSE: To describe both the common and less frequently encountered magnetic
resonance (MR) imaging features of radiation therapy–and chemotherapy-induced brain …

Post-treatment radiation and chemotherapy of malignant primary glial neoplasms present a
wide spectrum of tumor appearances and treatment-related entities. Radiologic findings of …

Purpose: To conduct a Phase II one-arm study to evaluate the long-term efficacy and safety
of accelerated fractionated radiotherapy combined with iv carboplatin for patients with …

Two patients with brain stem gliomas were treated with hyperfractionated radiation therapy
(HFR)(7,020 and 7,560 cGy, respectively). Despite initial clinical improvement during …

Out of 107 pts. treated with radio-and chemotherapy for low and high grade gliomas (TD: 45-
65Gy), 3 cases developed pathologically documented radionecrosis (coagulative necrosis …

Purpose: To conduct a Phase II one-arm study to evaluate the long-term efficacy and safety
of accelerated fractionated radiotherapy combined with intravenous carboplatin for patients …

Purpose: To see whether increasing the dose of hyperfractionated radiation therapy from 72
to 78 Gy would increase survival time in patients with gliomas, particularly those with brain …

Postoperative radiotherapy for low-grade gliomas has been shown in retrospective series to
improve survival, compared with surgery alone. To determine the proper radiotherapy …

Sixty-four adult patients with malignant glioma entered into a Phase II study on the use of
accelerated hyperfractionated radiation therapy. Histology included anaplastic astrocytoma …